BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 15719203)

  • 21. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD30 positive anaplastic large-cell lymphoma mimicking Langerhans cell histiocytosis.
    Ezra N; Van Dyke GS; Binder SW
    J Cutan Pathol; 2010 Jul; 37(7):787-92. PubMed ID: 19817947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic large cell lymphomas presented as bone lesions: a clinicopathologic study of six cases and review of the literature.
    Nagasaka T; Nakamura S; Medeiros LJ; Juco J; Lai R
    Mod Pathol; 2000 Oct; 13(10):1143-9. PubMed ID: 11048810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL).
    Massimino M; Spreafico F; Luksch R; Giardini R
    Med Pediatr Oncol; 2001 Aug; 37(2):97-102. PubMed ID: 11496346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
    Beljaards RC; Meijer CJ; Scheffer E; Toonstra J; van Vloten WA; van der Putte SC; Geerts ML; Willemze R
    Am J Pathol; 1989 Dec; 135(6):1169-78. PubMed ID: 2556926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
    Kim YC; Yang WI; Lee MG; Kim SN; Cho KH; Lee SJ; Lee MW; Koh JK
    Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomorphologic features of primary anaplastic large cell lymphoma of the psoas muscle: a case report and literature review.
    Recavarren RA; Yang J
    Diagn Cytopathol; 2010 Mar; 38(3):208-12. PubMed ID: 19760764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myxoid variant of anaplastic large cell lymphoma involving the skin: a case report.
    Gable AD; Clark SH; Magro CM
    J Cutan Pathol; 2012 Aug; 39(8):787-90. PubMed ID: 22612158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
    Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localized perineal cutaneous nodules: a case of recurrent systemic anaplastic large-cell lymphoma.
    Hernandez C; Puangsuvan SN; Peterson A; Robinson JK
    Clin Exp Dermatol; 2009 Dec; 34(8):e722-5. PubMed ID: 20055841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of CD30 (Ki-1) positive anaplastic large-cell lymphoma (ALCL). Review of the literature.
    de Kan R; van 't Veer MB
    Neth J Med; 1993 Dec; 43(5-6):277-84. PubMed ID: 8107936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
    Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
    Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.
    Benner MF; Willemze R
    Br J Dermatol; 2008 Nov; 159(5):1148-51. PubMed ID: 18782320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous anaplastic large-cell lymphoma.
    Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas.
    Bijl JJ; Rieger E; van Oostveen JW; Walboomers JM; Kreike M; Willemze R; Meijer CJ
    Am J Pathol; 1997 Oct; 151(4):1067-74. PubMed ID: 9327740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature.
    Kodama K; Hokama M; Kawaguchi K; Tanaka Y; Hongo K
    Neuropathology; 2009 Apr; 29(2):166-71. PubMed ID: 18564100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
    Lae ME; Ahmed I; Macon WR
    Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.